602 related articles for article (PubMed ID: 27780915)
1. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling.
Liang GH; Liu N; He MT; Yang J; Liang ZJ; Gao XJ; Rahhal AH; He QY; Zhang HT; Zha ZG
J Cell Biochem; 2018 Jan; 119(1):948-959. PubMed ID: 28681940
[TBL] [Abstract][Full Text] [Related]
3. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.
Chang J; Li Y; Wang X; Hu S; Wang H; Shi Q; Wang Y; Yang Y
Sci Rep; 2017 Aug; 7(1):7605. PubMed ID: 28790389
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
[TBL] [Abstract][Full Text] [Related]
5. Titanium particle-induced osteogenic inhibition and bone destruction are mediated by the GSK-3β/β-catenin signal pathway.
Gu Y; Wang Z; Shi J; Wang L; Hou Z; Guo X; Tao Y; Wu X; Zhou W; Liu Y; Zhang W; Xu Y; Yang H; Xue F; Geng D
Cell Death Dis; 2017 Jun; 8(6):e2878. PubMed ID: 28617442
[TBL] [Abstract][Full Text] [Related]
6. TWIST interacts with β-catenin signaling on osteosarcoma cell survival against cisplatin.
Wu J; Liao Q; He H; Zhong D; Yin K
Mol Carcinog; 2014 Jun; 53(6):440-6. PubMed ID: 23280703
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
[TBL] [Abstract][Full Text] [Related]
8. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation.
Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G
J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117
[TBL] [Abstract][Full Text] [Related]
9. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
[TBL] [Abstract][Full Text] [Related]
11. Revealing the effect of 6-gingerol, 6-shogaol and curcumin on mPGES-1, GSK-3β and β-catenin pathway in A549 cell line.
Eren D; Betul YM
Chem Biol Interact; 2016 Oct; 258():257-65. PubMed ID: 27645308
[TBL] [Abstract][Full Text] [Related]
12. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
[TBL] [Abstract][Full Text] [Related]
13. Activation of AKT1/GSK-3β/β-Catenin-TRIM11/Survivin Pathway by Novel GSK-3β Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model.
Darshit BS; Ramanathan M
Mol Neurobiol; 2016 Dec; 53(10):6716-6729. PubMed ID: 26660108
[TBL] [Abstract][Full Text] [Related]
14. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib inhibits β-catenin-dependent survival of the human osteosarcoma MG-63 cell line.
Xia JJ; Pei LB; Zhuang JP; Ji Y; Xu GP; Zhang ZP; Li N; Yan JL
J Int Med Res; 2010; 38(4):1294-304. PubMed ID: 20926002
[TBL] [Abstract][Full Text] [Related]
16. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer.
Cho YJ; Yoon J; Ko YS; Kim SY; Cho SJ; Kim WH; Park JW; Youn HD; Kim JH; Lee BL
APMIS; 2010 Oct; 118(10):782-90. PubMed ID: 20854473
[TBL] [Abstract][Full Text] [Related]
18. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth.
Holmes T; O'Brien TA; Knight R; Lindeman R; Shen S; Song E; Symonds G; Dolnikov A
Stem Cells; 2008 May; 26(5):1288-97. PubMed ID: 18323411
[TBL] [Abstract][Full Text] [Related]
20. Benzene metabolite hydroquinone induces apoptosis of bone marrow mononuclear cells through inhibition of β-catenin signaling.
Li J; Jiang S; Chen Y; Ma R; Chen J; Qian S; Shi Y; Han Y; Zhang S; Yu K
Toxicol In Vitro; 2018 Feb; 46():361-369. PubMed ID: 28886972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
